ERK1/2 regulates epidermal chemokine expression and skin inflammation

Saveria Pastore, Francesca Mascia, Feliciana Mariotti, Cristina Dattilo, Valentina Mariani, Giampiero Girolomoni

Research output: Contribution to journalArticlepeer-review


Resident cell populations of the skin contribute to the inflammatory response by producing an array of chemokines, which attract leukocytes from the circulation. TNF-α is a major inducer of proinflammatory mediators in keratinocytes. We have recently observed that epidermal growth factor receptor (EGFR) signaling affects TNF-α-driven chemokine expression in epidermal keratinocytes, and its functional impairment increases the levels of crucial chemoattractants such as CCL2/MCP-1, CCL5/RANTES, and CXCL10/IFN-γ- inducible protein-10. In this study, we report evidence that EGFR-dependent ERK1/2 activity is implicated in this mechanism. Abrogation of ERK1/2 activity with specific inhibitors increased chemokine expression in keratinocytes by enhancing mRNA stabilization. In mouse models, inflammatory response to irritants and T cell-mediated contact hypersensitivity were both aggravated when elicited in a skin area previously treated with an EGFR or a MAPK kinase 1/2 inhibitor. In contrast, impairment of p38αβ MAPK phosphorylation markedly attenuated these responses. Our data indicate that EGFR-dependent ERK1/2 activity in keratinocytes takes part to a homeostatic mechanism regulating inflammatory responses, and emphasize the distinct role of MAPKs as potential targets for manipulating inflammation in the skin.

Original languageEnglish
Pages (from-to)5047-5056
Number of pages10
JournalJournal of Immunology
Issue number8
Publication statusPublished - Apr 15 2005

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'ERK1/2 regulates epidermal chemokine expression and skin inflammation'. Together they form a unique fingerprint.

Cite this